RadNet (RDNT) Competitors

RadNet (NASDAQ:RDNT) and Veracyte (NASDAQ:VCYT) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, risk, profitability, institutional ownership, media sentiment, valuation, community ranking, earnings and analyst recommendations.

Does the media prefer RDNT or VCYT?

In the previous week, RadNet had 4 more articles in the media than Veracyte. MarketBeat recorded 8 mentions for RadNet and 4 mentions for Veracyte. Veracyte's average media sentiment score of 0.76 beat RadNet's score of -0.12 indicating that Veracyte is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
RadNet	2 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Veracyte	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Do analysts prefer RDNT or VCYT?

RadNet currently has a consensus price target of $30.00, indicating a potential downside of 6.54%. Veracyte has a consensus price target of $30.20, indicating a potential upside of 16.87%. Given Veracyte's higher probable upside, analysts plainly believe Veracyte is more favorable than RadNet.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
RadNet	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	3.00
Veracyte	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50

Which has stronger valuation and earnings, RDNT or VCYT?

RadNet has higher revenue and earnings than Veracyte. RadNet is trading at a lower price-to-earnings ratio than Veracyte, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
RadNet	$1.43 billion	1.31	$10.65 million	-$0.24	-133.74
Veracyte	$296.54 million	6.31	-$36.56 million	-$0.41	-63.02

Do insiders & institutionals believe in RDNT or VCYT?

68.3% of RadNet shares are held by institutional investors. 4.4% of RadNet shares are held by insiders. Comparatively, 2.9% of Veracyte shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Is RDNT or VCYT more profitable?

RadNet has a net margin of -0.90% compared to Veracyte's net margin of -9.70%. RadNet's return on equity of 3.28% beat Veracyte's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
RadNet	-0.90%	3.28%	0.67%
Veracyte	-9.70%	-2.83%	-2.63%

Which has more volatility and risk, RDNT or VCYT?

RadNet has a beta of 1.65, meaning that its share price is 65% more volatile than the S&P 500. Comparatively, Veracyte has a beta of 1.38, meaning that its share price is 38% more volatile than the S&P 500.

Does the MarketBeat Community believe in RDNT or VCYT?

Veracyte received 88 more outperform votes than RadNet when rated by MarketBeat users. Likewise, 73.14% of users gave Veracyte an outperform vote while only 67.20% of users gave RadNet an outperform vote.

Company	Underperform	Outperform
RadNet	Outperform Votes 334 67.20%	Underperform Votes 163 32.80%
Veracyte	Outperform Votes 422 73.14%	Underperform Votes 155 26.86%

Summary

RadNet beats Veracyte on 11 of the 18 factors compared between the two stocks.